Necitumumab (anti-EGFR)

Ask supplier a question | View on supplier's website

Necitumumab (anti-EGFR) is an epidermal growth factor receptor (EGFR) antagonist that can be used in combination with gemcitabine and cisplatin for the first-line treatment of patients with metastatic squamous non-small cell lung cancer.

Supplier	Selleck Chemicals
Product #	A2048
Sku #	A2048-1mg*5
Pricing	1mg*5, $849.00

Feedback